EC approves Pfizer’s ABRYSVO RSV vaccine for infants and older adults

Pallavi Madhiraju- August 28, 2023 0

Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for ABRYSVO, its bivalent respiratory syncytial virus (RSV) prefusion F vaccine. This groundbreaking ... Read More

FDA greenlights Pfizer’s ABRYSVO vaccine for shielding infants from RSV

Pallavi Madhiraju- August 23, 2023 0

The US Food and Drug Administration (FDA) has granted approval to Pfizer Inc.'s ABRYSVO, a bivalent Respiratory Syncytial Virus prefusion F (RSVpreF) vaccine. This cutting-edge ... Read More